Infusive’s ‘Weight Loss Economics Research’ was featured lasts week in Scott Galloways 2024 Predictions Live Event last week.
It was a great hour of research, insights and discussion.
For those who haven’t read it, here the 3 key takeaways from our Weight-Loss Economics analysis:
- Weight-loss drugs including Ozempic and Wegovy, have seen an explosion of interest and adoption, seeing Pharmetcuitcal producer Novo Nordisk to become the most valueable company in Europe.
- The drugs work by supressing appretite, and users can see reduction in up to 25% of their body weight in a year
- If these drugs were adopted at Covid-vaccine like rates, the impact to calorie consumption worldwide would be 3-4%, and it would cost over $1 trillion at current prices.
To read more about this, follow this link to our analysis infusive.com/insights
To read more of Scott Galloways work, find him here.